Seres Therapeutics, Inc. (MCRB) Analyst Forecast

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$9
Day's range
$9.5

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
06/07/2024 Chardan Capital Keay Nakae $1.25 $0.85   46.52%

Seres Therapeutics Inc FAQ's

Seres Therapeutics Inc has been rated by research analysts at Chardan Capital in the past 90 days.